Persistent bacteremia from Pseudomonas aeruginosa resistant to the novel antibiotics ceftolozane-tazobactam and ceftazidime-avibactam

被引：0
|
作者：
Gangcuangco, L. M. [1 ]
Clark, P. [2 ]
Stewart, C. [2 ]
Miljkovic, G. [1 ]
Saul, Z. [1 ]
机构：
[1] Bridgeport Hosp Yale New Haven Hlth, Dept Med, Bridgeport, CT USA
[2] Bridgeport Hosp, Dept Microbiol, Bridgeport, CT USA
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
PS1.356.LB
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [1] Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
    Gangcuangco, Louie Mar
    Clark, Patricia
    Stewart, Cynthia
    Miljkovic, Goran
    Saul, Zane K.
    CASE REPORTS IN INFECTIOUS DISEASES, 2016, 2016
  • [2] Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary
    O'Neall, Dustin
    Juhasz, Emese
    Toth, Akos
    Urban, Edit
    Szabo, Judit
    Melegh, Szilvia
    Katona, Katalin
    Kristof, Katalin
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (01) : 61 - 65
  • [3] Evaluation of the In vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Bilgin, Melek
    Basbulut, Ese
    Isler, Hacer
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 713 - 719
  • [4] Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates
    Humphries, Romney M.
    Hindler, Janet A.
    Wong-Beringer, Annie
    Miller, Shelley A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [5] Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia
    Shah, Sunish
    Kline, Ellen G.
    Haidar, Ghady
    Squires, Kevin M.
    Pogue, Jason M.
    Mccreary, Erin K.
    Ludwig, Justin
    Clarke, Lloyd G.
    Stellfox, Madison
    Van Tyne, Daria
    Shields, Ryan K.
    CLINICAL INFECTIOUS DISEASES, 2024, 80 (01) : 24 - 28
  • [6] Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
    Buehrle, Deanna J.
    Shields, Ryan K.
    Chen, Liang
    Hao, Binghua
    Press, Ellen G.
    Alkrouk, Ammar
    Potoski, Brian A.
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3227 - 3231
  • [7] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
  • [8] Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
    Shields, Ryan K.
    Clancy, Cornelius J.
    Pasculle, A. William
    Press, Ellen G.
    Haidar, Ghady
    Hao, Binghua
    Chen, Liang
    Kreiswirth, Barry N.
    Nguyen, M. Hong
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (02)
  • [9] Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
    Hareza, Dariusz A.
    Cosgrove, Sara E.
    Bonomo, Robert A.
    Dzintars, Kathryn
    Karaba, Sara M.
    Hawes, Armani M.
    Tekle, Tsigereda
    Simner, Patricia J.
    Tamma, Pranita D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)
  • [10] Monotherapy of ceftazidime-avibactam and ceftolozane-tazobactam against multidrug-resistant organisms
    Alatoom, Adnan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 126 - 126
12345